Repligen | Ativo Circulante



Current Assets Alterar Data
Agilent USD 4.21B 101M 2025-04
Align Technology USD 2.45B 46.03M 2025-06
Bio Techne USD 608.3M 18.94M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Bruker USD 2.16B 51.2M 2025-06
Charles River Laboratories USD 1.47B 36.5M 2025-06
Danaher USD 11B 1.47B 2025-06
Dentsply International USD 1.98B 232M 2025-03
Exact Sciences USD 1.37B 201.08M 2025-03
General Electric Aerospace USD 37.8B 226M 2025-06
Henry Schein USD 4.24B 206M 2025-06
Illumina USD 2.64B 32M 2025-06
IQVIA Holdings USD 6.35B 434M 2025-06
Mettler Toledo International USD 1.24B 79.67M 2025-06
Myriad Genetics USD 287.2M 10.8M 2025-03
Pfizer USD 43.7B 2.16B 2025-06
Repligen USD 1.03B 33.58M 2025-03
Revvity USD 2.24B 81.76M 2025-06
Standard Biotools USD 375.88M 77.73M 2024-12
Thermo Fisher Scientific USD 24.58B 1.21B 2025-06
Waters USD 1.78B 42.24M 2025-06
West Pharmaceutical Services USD 1.68B 223.4M 2025-06


Repligen Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.